EUROLAB
astm-f2255-acute-systemic-toxicity
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ASTM F2255 Acute Systemic Toxicity Laboratory Testing Service: A Comprehensive Guide

Standard-Related Information

The ASTM F2255 standard is a widely accepted method for assessing the acute systemic toxicity of materials and substances. This standard is developed by the American Society for Testing and Materials (ASTM), a leading standards development organization that provides technical guidelines and specifications for various industries.

Legal and Regulatory Framework

The legal and regulatory framework surrounding ASTM F2255 testing is governed by international and national standards, including:

  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and risk management
  • EN ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and risk management
  • TSE (Turkish Standards Institution) TS EN ISO 10993-1:2009
  • These standards require manufacturers to assess the biocompatibility and safety of their products, including evaluating acute systemic toxicity.

    International and National Standards

    ASTM F2255 testing is governed by various international and national standards, which ensure that the test results are accurate and reliable. The relevant standards include:

  • ASTM F2255-19 Standard Guide for Determining Acute Systemic Toxicity of Materials
  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and risk management
  • EN ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and risk management
  • Standard Development Organizations

    The standard development process involves various organizations, including:

  • American Society for Testing and Materials (ASTM)
  • International Organization for Standardization (ISO)
  • European Committee for Standardization (CEN)
  • These organizations work together to develop and maintain standards that ensure the safety and reliability of products.

    Evolution and Updates of Standards

    Standards evolve over time as new technologies emerge, and research findings become available. The standard development process involves continuous review and updates to reflect changes in science and technology.

    Standard Numbers and Scope

    The following are some of the relevant standard numbers and their scope:

  • ASTM F2255-19: Standard Guide for Determining Acute Systemic Toxicity of Materials
  • This standard provides a guide for determining acute systemic toxicity using in vivo testing methods.

  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and risk management
  • This standard provides guidelines for evaluating the biological safety of medical devices, including assessing acute systemic toxicity.

    Standard Compliance Requirements

    Manufacturers must comply with relevant standards when conducting ASTM F2255 testing. The compliance requirements vary depending on industry, country, or region.

  • Industry-specific standards: Various industries have their own specific standards for evaluating acute systemic toxicity.
  • National and international regulatory requirements: Manufacturers must comply with national and international regulations when conducting ASTM F2255 testing.
  • Conformity assessment: Manufacturers must demonstrate conformity to relevant standards through testing, inspection, or certification.
  • Standard Requirements and Needs

    ASTM F2255 testing is required for various industries, including:

  • Medical devices
  • Pharmaceuticals
  • Cosmetics
  • Chemicals
  • The business and technical reasons for conducting ASTM F2255 testing include:

  • Ensuring product safety and reliability
  • Meeting regulatory requirements
  • Reducing the risk of product liability claims
  • Enhancing customer confidence and trust
  • Improving international market access and trade facilitation
  • Consequences of Not Performing This Test

    Failure to conduct ASTM F2255 testing can result in:

  • Product recalls
  • Regulatory penalties
  • Loss of business reputation
  • Decreased customer confidence and trust
  • Quality Assurance and Quality Control Aspects

    ASTM F2255 testing involves strict quality assurance and quality control measures, including:

  • Calibration and validation: Equipment and instruments must be calibrated and validated regularly.
  • Sample preparation: Samples must be prepared according to standard procedures.
  • Testing parameters and conditions: Testing parameters and conditions must be documented and followed.
  • Measurement and analysis methods: Measurement and analysis methods must be accurate and reliable.
  • Test Conditions and Methodology

    The following is a detailed step-by-step explanation of how ASTM F2255 testing is conducted:

    1. Sample preparation

    2. Testing equipment and instruments calibration

    3. Testing environment setup (temperature, humidity, pressure)

    4. Testing parameters and conditions selection

    5. Measurement and analysis methods implementation

    6. Data collection and recording

    7. Quality control measures during testing

    Test Reporting and Documentation

    ASTM F2255 test results are documented and reported in a standard format, including:

  • Test report: A detailed report of the testing process, including testing parameters and conditions.
  • Test certificate: A certification document that attests to the accuracy and reliability of the test results.
  • Why This Test Should Be Performed

    The benefits and advantages of performing ASTM F2255 testing include:

  • Ensuring product safety and reliability
  • Meeting regulatory requirements
  • Reducing the risk of product liability claims
  • Enhancing customer confidence and trust
  • Conclusion

    ASTM F2255 testing is a critical component of ensuring product safety and reliability. Manufacturers must comply with relevant standards, including ASTM F2255-19, ISO 10993-1:2018, and EN ISO 10993-1:2009.

    By performing ASTM F2255 testing, manufacturers can:

  • Ensure product safety and reliability
  • Meet regulatory requirements
  • Reduce the risk of product liability claims
  • Enhance customer confidence and trust
  • About Us

    We are a leading laboratory testing services provider that offers ASTM F2255 testing. Our expert team is dedicated to providing accurate and reliable test results.

    Contact Us

    For more information on our ASTM F2255 testing services, please contact us at insert contact details.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers